gastric bypass glp-1 Anti-obesity drugs are closing the gap between dieting and bariatric surgery | Diet and Nutrition | Prevention Interest in Treatment with GLP-1

For weight management, Wegovy (semaglutide) and Saxenda (liraglutide) are licensed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with weight-related comorbidities

Statements Author contributions AA: Project administration, Formal analysis, Resources, Data curation, Writing original draft, Methodology, Visualization, Conceptualization, Supervision, Investigation, Validation, Software, Funding acquisition, Writing review & editing

Copays, coinsurance, deductibles may apply

For example, Kroger, H-E-B, and Hy-Vee are rolling out such programs that include wellness visits, nutritional counseling, private-label products, and access to prescription services that include GLP-1s